Tracking Mutations In Cell-Free DNA May Improve Minimal Residual Disease Detection In Patients With Breast Cancer, Study Indicates

Cancer Network (3/13, Slater) reported researchers “found that tracking large numbers of individualized tumor mutations in cell-free DNA can improve minimal residual disease detection in patients with breast cancer; however, its sensitivity is driven by t...